Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Income Statement [Abstract]    
Revenue $ 512,500
Operating costs and expenses:    
Inventor royalties, contingent legal fees, litigation and licensing expenses 385,002
Research and development expenses (including non-cash share based compensation expenses of $4,165,668 and $1,484,545, respectively) 6,189,692 4,381,205
General and administrative expenses (including non-cash share based compensation expenses of $3,892,410 and $2,652,915, respectively) 7,073,498 5,596,997
Total operating costs and expenses 13,648,192 9,978,202
Loss from operations (13,135,692) (9,978,202)
Gain (loss) on disposal of property and equipment 5,447 (148,084)
Interest income 2,322 33,923
Net loss (13,127,923) (10,092,363)
Less: Net loss attributable to noncontrolling interest (173,523) (74,008)
Net loss attributable to common stockholders $ (12,954,400) $ (10,018,355)
Net loss per share:    
Basic and diluted $ (0.45) $ (0.45)
Weighted average common shares outstanding:    
Basic and diluted 28,578,892 22,229,042